Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders
| العنوان: | Temporal dynamics of symptom change among veterans receiving an integrated treatment for posttraumatic stress disorder and substance use disorders |
|---|---|
| المؤلفون: | Nicholas P. Allan, Daniel F. Gros, Amanda K. Gilmore, Christal L. Badour, Sudie E. Back, Therese K. Killeen, Kateryna Kolnogorova, Julianne C. Flanagan, Kristina J. Korte, Delisa G. Brown |
| المصدر: | J Trauma Stress |
| بيانات النشر: | Wiley, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Substance-Related Disorders, Frequency of use, Implosive Therapy, Comorbidity, Relapse prevention, Article, law.invention, Stress Disorders, Post-Traumatic, Randomized controlled trial, law, mental disorders, Humans, Medicine, Veterans, business.industry, Multilevel model, Cognition, United States, Additional research, Psychiatry and Mental health, Clinical Psychology, Posttraumatic stress, Treatment Outcome, Substance use, business, Clinical psychology |
| الوصف: | The present study examined temporal patterns of symptom change during treatment for comorbid posttraumatic stress disorders (PTSD) and substance use disorders (SUDs). We hypothesized that PTSD symptom severity would predict subsequent-session substance use and that this association would be particularly strong among patients who received an integrated treatment versus SUD-only treatment. Participants were 81 United States military veterans with current PTSD and an SUD who were enrolled in a 12-week, randomized controlled trial examining the efficacy of an integrated treatment called Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE) compared with cognitive behavioral relapse prevention therapy (RP). Lagged multilevel models indicated that PTSD symptom improvement did not significantly predict the likelihood of next-session substance use (likelihood of use: B = 0.03, SE = 0.02, p = .141; percentage of days using B = -0.02, SE = 0.01, p = .172. Neither substance use, B = 1.53, SE = 1.79, p = .391, nor frequency of use, B = 0.26, SE = 0.50, p = .612, predicted next-session PTSD symptom severity in either treatment condition. Stronger associations between PTSD symptoms and next-session substance use were expected given the self-medication hypothesis. Additional research is needed to better understand the temporal dynamics of symptom change as well as the specific mediators and mechanisms underlying symptom change. |
| تدمد: | 1573-6598 0894-9867 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40f61a7954d7ad260886c1354afda7bb https://doi.org/10.1002/jts.22769 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....40f61a7954d7ad260886c1354afda7bb |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15736598 08949867 |
|---|